Scott Rocklage is the current CEO of 5 AM Ventures. He acquired this position in 2004. As the CEO, he has managed to introduce visionary leadership for 5 AM Ventures. Under his visionary leadership, the company has been in an excellent position to accomplish various goals and objectives. 5 AM Company has gained stability which stands to be one of the most critical goals for multiple companies.
What was so special about Scott Rocklage in comparison with his co-executive in the company?
Scott Rocklage has been in the healthcare industry for more than three decades serving as a manager in the healthcare industry. Scott has offered visionary and strategic leadership that has resulted to the confirmation of the three United States New Drug applications. He played a tremendous role in getting the approval for Teslascan, Omniscan as well as Cubicin.
Before he became the co-manager of the 5 AM Ventures Company, Scott Rocklage used to serve as the Chairman as well as the CEO of Cubist Pharmaceuticals. He also used to be the President and the CEO of Nycomed Salutar. In addition to these ranks, Scoff also held some positions at Catalytica and Salutar as well. During his career, Scott Rocklage used to work as the Board Chairman of another company known as Relypsa and Novira. At these positions, Scott Rocklage has been able to provide quality leadership as well as expertise. In conjunction with being the managing partner of the 5 AM Ventures Company, Dr. Scott Rocklage is the Current Board chairman of Cidara, Kinestral, and Rennovia.
He is also serving in another company known as Epirus where he is currently serving on Board. Before working in this company, Rocklage worked as the Semprus executive chairman, Ilypsa, and Milkana. Before his healthcare profession, Scott attained a bachelor’s degree award in Chemistry. He attained his undergraduate degree at the California University which is based in Berkeley. After his undergraduate, he pursued a Ph.D. in Chemistry. He pursued his Ph.D. at MIT-Massachusetts Institute of Technology. It was during this time that he operated research in the Richard R. Schrock’s laboratory. Richard was the Winner of Nobel Prize in Chemistry in 2015.
Connect with Scott Rocklage on LinkedIn.